News Home

Should Drug Manufacturers - General Stock Pfizer Inc. (PFE) Be in Your Portfolio Friday?

Friday, September 17, 2021 01:50 PM | InvestorsObserver Analysts
Should Drug Manufacturers - General Stock Pfizer Inc. (PFE) Be in Your Portfolio Friday?

The 63 rating InvestorsObserver gives to Pfizer Inc. (PFE) stock puts it near the top of the Drug Manufacturers - General industry. In addition to scoring higher than 88 percent of stocks in the Drug Manufacturers - General industry, PFE’s 63 overall rating means the stock scores better than 63 percent of all stocks.

Overall Score - 63
PFE has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on PFE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 63 would rank higher than 63 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Pfizer Inc. Stock Today?

Pfizer Inc. (PFE) stock is trading at $43.90 as of 1:44 PM on Friday, Sep 17, a decline of -$0.56, or -1.27% from the previous closing price of $44.46. The stock has traded between $43.88 and $44.46 so far today. Volume today is below average. So far 16,292,062 shares have traded compared to average volume of 38,439,797 shares. Click Here to get the full Stock Report for Pfizer Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App